Healthpeak Properties, Inc. PEAK
17.10 0.00 (+0.00%)
At closeMar 1, 2024, 4:00 PM EST
16.51 Day range 17.14
52-week range unavailable
- Market cap
- 9.36B
- Revenue (ttm)
- 2.18B
- Profit margin
- 14.03%
- Shares out
- 547.17M
- Forward P/E
- 31.09
- Dividend
- 1.20 (7.02%)
- Ex-dividend date
- Feb 12, 2024
- Volume
- 9.98M
- Open
- 16.74
- Previous close
- 17.10
- Day's range
- 16.51 – 17.14
- Beta
- 1.00
- Analysts
- Buy
- Price target
- 21.82 (+27.6%)
- Earnings date
- Apr 25, 2024
No chart data for this range yet.
Key statistics
- Enterprise value
- 16.74B
- PEG ratio
- -3.50
- Price / sales
- 4.35
- Price / book
- 1.47
- Dividend yield
- 7.02%
- Payout ratio
- 214.29%
- Revenue growth
- 5.60%
- Free cash flow
- 954.23M
- Total cash
- 138.99M
- Total debt
- 7.08B
- Return on equity
- 4.71%
- Short % of float
- 2.22%
- 50-day average
- 18.15
- 200-day average
- 18.94
Analyst view
Consensus: buy
Buy
Price target (mean) 21.82 +27.6% upside
Now 17.10
- Target (low)
- 18.00
- Target (mean)
- 21.82
- Target (high)
- 26.00
Ratings (-1m) 15 9 buy · 4 hold · 2 sell
- Strong buy5
- Buy4
- Hold4
- Sell2
- Strong sell0
Next earnings
Apr 25, 2024
Expected Apr 25, 2024. Consensus EPS estimate 0.07.
Financials — quick view
PEAK Revenue — quarterly 553.65M
PEAK Net income — quarterly 70.94M
PEAK EPS — quarterly 0.13
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 25, 2024 | Mar 1, 2024 | 0.44 | — | — | — |
| Feb 8, 2024 | Dec 1, 2023 | 0.45 | — | — | — |
| Oct 30, 2023 | Sep 1, 2023 | 0.44 | — | — | — |
| Jul 27, 2023 | Jun 1, 2023 | 0.44 | — | — | — |
| Apr 27, 2023 | Mar 1, 2023 | 0.42 | — | — | — |
| Feb 7, 2023 | Dec 1, 2022 | 0.43 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2023 | Exane BNP Paribas | init | — | Underperform |
| Oct 4, 2023 | Scotiabank | main | Sector Perform | Sector Perform |
| Oct 2, 2023 | Wedbush | init | — | Neutral |
| Sep 6, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Jul 24, 2023 | Barclays | main | Overweight | Overweight |
| Jun 14, 2023 | Mizuho | reit | Buy | Buy |
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
- Sector
- Real Estate
- Industry
- REIT—Healthcare Facilities
- Country
- United States
- Website
- healthpeak.com
News
Healthpeak Properties, Inc. (DOC) Q3 2026 Earnings Call Transcript 
Can PEAK:AIO Buyout Give NetApp a Competitive Edge in AI-Scale Storage? 
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 
PEAK:AIO and Los Alamos National Laboratory Launch Lattice - Breaking Open the Metadata Bottleneck in Parallel File Systems 
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting 
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting 
F45 Training Introduces F45 PEAK500: A New Era of Standardized Athletic Performance Testing 
Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR) 
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST) 
Y Intercept Hong Kong Ltd Raises Stock Holdings in Healthpeak Properties, Inc. $DOC
Your note
Sign in to keep a note on PEAK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALONSO LISA A | Officer | Stock Award(Grant) | Jan 31, 2024 | 17,534 |
| BRINKER SCOTT M | Chief Executive Officer | Purchase | Mar 1, 2023 | 206,525 |
| CARTWRIGHT BRIAN G. | Director | Stock Award(Grant) | Apr 27, 2023 | 53,514 |
| CONNOR JAMES B | Director | Stock Award(Grant) | Apr 27, 2023 | 8,203 |
| GARVEY CHRISTINE N | Director | Stock Award(Grant) | Apr 27, 2023 | 36,078 |
| GRIFFIN R KENT JR | Director | Stock Award(Grant) | Apr 27, 2023 | 60,219 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 16.10% | 88,088,596 | 1.77B | Jun 29, 2023 |
| Blackrock Inc. | 10.05% | 54,985,612 | 1.11B | Jun 29, 2023 |
| State Street Corporation | 7.22% | 39,522,044 | 794.39M | Jun 29, 2023 |
| Invesco Ltd. | 4.19% | 22,919,055 | 460.67M | Jun 29, 2023 |
| JP Morgan Chase & Company | 2.85% | 15,610,332 | 313.77M | Jun 29, 2023 |
| Norges Bank Investment Management | 2.82% | 15,420,407 | 386.59M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Specialized-Real Estate Index Fund | 4.21% | 23,050,639 | 503.20M | Jul 30, 2023 |
| Vanguard Total Stock Market Index Fund | 3.11% | 17,031,994 | 342.34M | Jun 29, 2023 |
| Vanguard 500 Index Fund | 2.38% | 13,024,104 | 261.78M | Jun 29, 2023 |
| Vanguard Mid-Cap Index Fund | 2.32% | 12,678,524 | 254.84M | Jun 29, 2023 |
| Fidelity 500 Index Fund | 1.12% | 6,118,585 | 122.13M | May 30, 2023 |
| SPDR S&P 500 ETF Trust | 1.10% | 6,017,258 | 123.84M | Aug 30, 2023 |